Michelle Rodolph

1.7k total citations · 1 hit paper
19 papers, 1.2k citations indexed

About

Michelle Rodolph is a scholar working on Infectious Diseases, Epidemiology and Sociology and Political Science. According to data from OpenAlex, Michelle Rodolph has authored 19 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Infectious Diseases, 16 papers in Epidemiology and 7 papers in Sociology and Political Science. Recurrent topics in Michelle Rodolph's work include HIV/AIDS Research and Interventions (17 papers), HIV, Drug Use, Sexual Risk (16 papers) and Sex work and related issues (7 papers). Michelle Rodolph is often cited by papers focused on HIV/AIDS Research and Interventions (17 papers), HIV, Drug Use, Sexual Risk (16 papers) and Sex work and related issues (7 papers). Michelle Rodolph collaborates with scholars based in Switzerland, United States and Thailand. Michelle Rodolph's co-authors include Ioannis Hodges-Mameletzis, Rachel Baggaley, Virginia A. Fonner, Caitlin E. Kennedy, Kevin O’Reilly, Sarah L Dalglish, Robert M. Grant, Annette Verster, Rachel Baggaley and Elie A. Akl and has published in prestigious journals such as SHILAP Revista de lepidopterología, Addiction and AIDS.

In The Last Decade

Michelle Rodolph

17 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effectiveness and safety of oral HIV preexposure prophylaxis for all populations

2016 725 citations Virginia A. Fonner, Sarah L Dalglish et al. AIDS profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michelle Rodolph Switzerland	11	1.1k	861	468	352	171	19	1.2k
Surinda Kawichai Thailand	22	1.1k 1.0×	939 1.1×	375 0.8×	475 1.3×	237 1.4×	47	1.4k
Robin J. MacGowan United States	21	894 0.8×	847 1.0×	369 0.8×	550 1.6×	211 1.2×	48	1.2k
Ioannis Hodges-Mameletzis Switzerland	13	1.4k 1.2×	928 1.1×	515 1.1×	437 1.2×	245 1.4×	20	1.5k
Somyot Kittimunkong Thailand	8	1.2k 1.1×	1.0k 1.2×	478 1.0×	224 0.6×	334 2.0×	11	1.3k
Manoj Leethochawalit Thailand	8	1.2k 1.1×	1.0k 1.2×	478 1.0×	224 0.6×	334 2.0×	9	1.3k
Jonathan E. Volk United States	17	1.3k 1.2×	1.1k 1.3×	493 1.1×	386 1.1×	212 1.2×	25	1.5k
Eduardo Valverde United States	20	908 0.8×	740 0.9×	245 0.5×	425 1.2×	174 1.0×	48	1.2k
Udomsak Sangkum Thailand	12	1.3k 1.2×	1.1k 1.3×	490 1.0×	244 0.7×	412 2.4×	16	1.5k
Andrea Mantsios United States	20	746 0.7×	668 0.8×	380 0.8×	171 0.5×	167 1.0×	35	953
Allison M. McFall United States	18	797 0.7×	870 1.0×	422 0.9×	220 0.6×	138 0.8×	54	1.2k

Countries citing papers authored by Michelle Rodolph

Since Specialization

Citations

This map shows the geographic impact of Michelle Rodolph's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle Rodolph with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle Rodolph more than expected).

Fields of papers citing papers by Michelle Rodolph

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle Rodolph. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle Rodolph. The network helps show where Michelle Rodolph may publish in the future.

Co-authorship network of co-authors of Michelle Rodolph

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle Rodolph. A scholar is included among the top collaborators of Michelle Rodolph based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle Rodolph. Michelle Rodolph is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Kennedy, Caitlin E., Ping Teresa Yeh, Michelle Rodolph, et al.. (2025). HIV post‐exposure prophylaxis in community settings and by lay health workers or through task sharing: a systematic review of effectiveness, case studies, values and preferences, and costs. Journal of the International AIDS Society. 28(5). e26448–e26448.

Zyl, Gert U. van, Mateo Prochazka, H Schmidt, et al.. (2025). Lenacapavir-associated drug resistance: implications for scaling up long-acting HIV pre-exposure prophylaxis. The Lancet HIV. 12(10). e732–e736. 1 indexed citations

Schmidt, H, et al.. (2025). Seizing the moment: the potential of PrEP choice and innovation to transform HIV prevention. Journal of the International AIDS Society. 28(S2). e26498–e26498. 1 indexed citations

Warren, Mitchell, et al.. (2023). Shaping and coordinating the implementation science agenda for injectable cabotegravir for PrEP: the role of the Biomedical Prevention Implementation Collaborative (BioPIC). Journal of the International AIDS Society. 26(S2). e26094–e26094. 4 indexed citations

Shaw, Graham, Robin Schaefer, H Schmidt, et al.. (2023). Pre-exposure prophylaxis (PrEP) for HIV prevention among people who inject drugs: a global mapping of service delivery. Harm Reduction Journal. 20(1). 16–16. 10 indexed citations

Straten, Ariane van der, Virginia A. Fonner, Kathleen Ridgeway, et al.. (2023). Systematic review of the values and preferences regarding the use of injectable pre‐exposure prophylaxis to prevent HIV acquisition. Journal of the International AIDS Society. 26(S2). e26107–e26107. 43 indexed citations

Fonner, Virginia A., Kathleen Ridgeway, Ariane van der Straten, et al.. (2023). Safety and efficacy of long-acting injectable cabotegravir as preexposure prophylaxis to prevent HIV acquisition. AIDS. 37(6). 957–966. 29 indexed citations

Schmidt, H, Robin Schaefer, Van Thi Thuy Nguyen, et al.. (2022). Scaling up access to HIV pre-exposure prophylaxis (PrEP): should nurses do the job?. The Lancet HIV. 9(5). e363–e366. 16 indexed citations

Schmidt, H, Michelle Rodolph, Robin Schaefer, Rachel Baggaley, & Meg Doherty. (2022). Long‐acting injectable cabotegravir: implementation science needed to advance this additional HIV prevention choice. Journal of the International AIDS Society. 25(7). e25963–e25963. 19 indexed citations

10.

Steyn, Petrus S., et al.. (2022). Integrating pre-exposure prophylaxis of HIV infection into family planning services: a scoping review. BMJ Sexual & Reproductive Health. 49(3). 210–218. 6 indexed citations

11.

Drake, Alison L., Nancy Kidula, Euphemia Sibanda, et al.. (2021). A Landscape Analysis of Offering HIV Testing Services Within Family Planning Service Delivery. SHILAP Revista de lepidopterología. 3. 657728–657728. 5 indexed citations

12.

Hodges-Mameletzis, Ioannis, et al.. (2018). Going global: the adoption of the World Health Organization’s enabling recommendation on oral pre-exposure prophylaxis for HIV. Sexual Health. 15(6). 489–500. 59 indexed citations

13.

Fonner, Virginia A., Sarah L Dalglish, Kevin O’Reilly, et al.. (2016). Values and Preferences on the Use of Oral Pre-exposure Prophylaxis (PrEP) for HIV Prevention Among Multiple Populations: A Systematic Review of the Literature. AIDS and Behavior. 21(5). 1325–1335. 163 indexed citations

14.

Fonner, Virginia A., Sarah L Dalglish, Caitlin E. Kennedy, et al.. (2016). Effectiveness and safety of oral HIV preexposure prophylaxis for all populations. AIDS. 30(12). 1973–1983. 725 indexed citations breakdown →

15.

Baggaley, Rachel, Shona Dalal, Cheryl Johnson, et al.. (2016). Beyond the 90‐90‐90: refocusing HIV prevention as part of the global HIV response. Journal of the International AIDS Society. 19(1). 21348–21348. 36 indexed citations

16.

Walsh, Nick, Annette Verster, Michelle Rodolph, & Elie A. Akl. (2014). WHO guidance on the prevention of viral hepatitis B and C among people who inject drugs. International Journal of Drug Policy. 25(3). 363–371. 60 indexed citations

17.

Liu, Wei, Jie Chen, Michelle Rodolph, et al.. (2007). HIV Incidence, Retention, and Changes of High-Risk Behaviors Among Rural Injection Drug Users in Guangxi, China. Substance Abuse. 27(4). 53–61. 17 indexed citations

18.

Liu, Wei, Jie Chen, Michelle Rodolph, et al.. (2006). HIV prevalence among injection drug users in rural Guangxi China. Addiction. 101(10). 1493–1498. 26 indexed citations

19.

Rodolph, Michelle. (2001). HIV policy formulation and strategic planning for the communication, transportation, post, construction and tourism sectors, Lao People's Democratic Republic. Medical Entomology and Zoology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact